Filing Flows › Nu Skin Enterprises (NUS) › Q2 2026 › vs Q1 2026
Nu Skin Enterprises (NUS) Q2 2026 vs Q1 2026 (quarter over quarter)
Nu Skin Enterprises's revenue fell $496K (-0.2%) from $321M in Q1 2026 to $320M in Q2 2026.
Nu Skin Enterprises, Q2 2026: revenue $320M (-17% year over year), operating margin -18.5%, net loss $250M, operating cash flow $10.6M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 1.6% | -5.5% | +7.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $320M | $321M | −$496K | -0.2% |
| Net loss | $250M | −$1.8M | $252M | — |
| Costs & expenses | $570M | $321M | $249M | +78% |
| Operating costs | $379M | $317M | $62.8M | +20% |
| Interest & other, net | $3.9M | $1.4M | $2.4M | +170% |
| Income tax | $187M | $763K | $186M | 245× |
| Cost of revenue | $102M | $106M | −$4.4M | -4% |
| Sales & marketing | $108M | $110M | −$2.1M | -2% |
| General & admin | $90.8M | $98.5M | −$7.7M | -8% |
| Other operating costs | $78.9M | $1.8M | $77.0M | 43× |
| Operating cash sources | $260M | −$5.8M | $266M | — |
| Depreciation & amortization | $12.7M | $12.3M | $316K | +3% |
| Share-based compensation | $1.1M | $3.7M | −$2.6M | -70% |
| Working capital & other | $247M | −$21.8M | $268M | — |
| Net loss absorbed | $250M | −$1.8M | $252M | — |
| Operating cash flow | $10.6M | −$3.9M | $14.5M | — |
| Free cash flow (OCF − capex) | $5.0M | −$17.6M | $22.6M | — |
| Capital expenditures | $5.6M | $13.7M | −$8.1M | -59% |
Questions
How much did Nu Skin Enterprises's revenue grow quarter over quarter in Q2 2026?
Nu Skin Enterprises's revenue fell $496K (-0.2%) from $321M in Q1 2026 to $320M in Q2 2026.